Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.

@article{Cotter2003PriorPA,
  title={Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.},
  author={Gad Cotter and Christopher Paul Cannon and Carolyn H. McCabe and Yoav Michowitz and Edo Kaluski and Andrew Charlesworth and Olga Milo and Jane Bentley and Alex Blatt and Rikardo Krakover and Reuven Zimlichman and Leonardo H. Reisin and Alon T Marmor and Basil S. Lewis and Zvi Vered and Avi Caspi and Eugene Braunwald},
  journal={American heart journal},
  year={2003},
  volume={145 4},
  pages={622-7}
}
BACKGROUND Cerebrovascular accidents (CVAs), transient ischemic attacks (TIAs), and peripheral arterial disease (PAD) frequently coexist with coronary artery disease (CAD) and were previously reported to adversely affect the prognosis of patients with chronic CAD. METHODS We examined the effect of prior CVA/TIA or PAD (extra-cardiac vascular disease [EVD]) on the outcome of 10,281 patients with acute coronary syndromes enrolled in the Orbofiban in Patients with Unstable Coronary Syndromes… CONTINUE READING